MedPath

An open label randomized controlled trial of tacrolimus versus cyclosporine treatment for severe ulcerative colitis

Not Applicable
Recruiting
Conditions
lcerative colitis
Registration Number
JPRN-UMIN000010776
Lead Sponsor
Chiba University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who had treated with tacrolimus or cyclosporine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical response rates at 2 weeks of treatment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath